Drug Profile
Telmisartan/ramipril
Alternative Names: Ramipril/telmisartan; Telmisartan/ramipril FDC - Boehringer IngelheimLatest Information Update: 25 Aug 2014
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim
- Class Antihypertensives; Benzimidazoles; Benzoates; Heterocyclic bicyclo compounds
- Mechanism of Action ACE inhibitors; Angiotensin type 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cardiovascular disorders; Hypertension